Abstract:
Objective To explore the correlation between complement level of C3,other risk factors and cognitive dysfunction in patients with end-stage renal disease(ESRD).
Methods From July 2019 to July 2021,medical records and laboratory examinations were collected from 92 ESRD patients. Serum levels of C3 and C4 were detected by immunoturbidimetry. The Montreal Cognitive Assessment scale(MoCA)was employed for assessing the level of cognitive function. According to MoCA score, they were divided into two groups of cognitive impairment(MoCA score <26)and non-cognitive impairment(MoCA score ≥ 26). General profiles,laboratory parameters,scale scores and serum levels of complements C3 and C4 of two groups were compared. Multivariate Logistic stepwise regression analysis was utilized for examining whether or not serum level of complement C3 was an independent influencing factor of cognitive dysfunction.
Results Among them,55(59. 78%)had cognitive dysfunction. Differences in age,education duration,serum creatinine,estimated glomerular filtration rate(eGFR),serum phosphorus,calcium-phosphorus product,serum albumin,prognosis of nutrition index,total cholesterol,low-density lipoprotein cholesterol,serum iron,C-reactive protein(CRP)and HAMA/HAMD score were statistically significant(
P<0. 05). Inter-group comparison of serum complement level indicated that serum level of complement C3 had statistical significance(
P<0. 05)while serum level of complement C4 had no statistical significance (
P>0. 05). Multivariate Logistic stepwise regression analysis revealed that except for education duration(
OR=0. 792,
P=0. 032),depression degree(
OR=1. 252,
P=0. 006)and eGFR level(
OR=0. 745,
P=0. 005),serum level of complement C3(
OR=1. 041,
P=0. 021)was also an independent influencing factor of cognitive function. Elevated serum level of complement C3 was an independent risk factor for cognitive dysfunction in ESRD patients.
Conclusion The incidence of cognitive dysfunction remains high in ESRD patients and it is affected by many factors. And a rising serum level of complement C3 may be closely correlated with the occurrence of cognitive dysfunction.